Stockscreener 앱 받기
0.789
4.69%
0.0347
전일 마감가:
$0.7543
열려 있는:
$0.7549
하루 거래량:
2.66M
Relative Volume:
0.64
시가총액:
$171.06M
수익:
-
순이익/손실:
$-90.60M
주가수익비율:
-1.2587
EPS:
-0.6268
순현금흐름:
$-68.88M
1주 성능:
+19.60%
1개월 성능:
+19.65%
6개월 성능:
-41.50%
1년 성능:
+69.21%
1일 변동 폭
$0.75
$0.82
1주일 범위
$0.6666
$0.82
52주 변동 폭
$0.36
$2.35
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
명칭
Tenaya Therapeutics Inc
전화
415-865-2066
주소
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.7883 | 163.68M | 0 | -90.60M | -68.88M | -0.6268 |
VRTX
Vertex Pharmaceuticals Inc
|
424.72 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
717.69 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.25 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.32 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
314.11 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-10 | 개시 | William Blair | Outperform |
| 2023-11-30 | 개시 | Leerink Partners | Outperform |
| 2022-06-15 | 개시 | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc 주식(TNYA)의 최신 뉴스
symbol__ Stock Quote Price and Forecast - CNN
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Alnylam’s research pact worth up to $1.1B sends Tenaya higher - MSN
Tenaya Therapeutics (NASDAQ:TNYA) Stock Price Down 4.4%Here's Why - MarketBeat
TNYA Technical Analysis | Trend, Signals & Chart Patterns | TENAYA THERAPEUTICS INC (NASDAQ:TNYA) - ChartMill
TNYA pulls back after hours following significant $1.13B deal-spurred rally - MSN
Tenaya to present TN-401 gene therapy trial data at ASGCT - Investing.com UK
Tenaya Therapeutics to present new clinical data from RIDGE-1 Phase 1b/2 TN-401 trial at ASGCT - Traders Union
Tenaya to present TN-401 gene therapy trial data at ASGCT By Investing.com - Investing.com South Africa
Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026 - The Manila Times
Tenaya to show 1-year heart gene therapy data in late-breaking talk - Stock Titan
Tenaya Therapeutics (TNYA) price target increased by 11.11% to 10.20 - MSN
TNYA.O Technical Analysis & Stock Price Forecast - Intellectia AI
TNYA (Tenaya Therapeutics) posts slight Q4 2025 EPS beat, but shares drop 5.2 percent on soft investor sentiment.Trending Social Stocks - Xã Thanh Hà
TNYA Tenaya Therapeutics Inc. shares gain over 4 percent after Q4 2025 earnings narrowly top analyst consensus estimates.Crowd Consensus Signals - UBND thành phố Hải Phòng
TNYA.O PE Ratio & Valuation, Is TNYA.O Overvalued - Intellectia AI
TNYA Should I Buy - Intellectia AI
TNYA News & Events - Intellectia AI
Does Tenaya Therapeutics (TNYA) stock carry significant risk | Q4 2025: Better Than ExpectedAI Powered Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
When Will Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Become Profitable? - Yahoo Finance
TNYA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
When to Sell Tenaya Therapeutics (TNYA) Stock (Smart Money Exits) 2026-04-16Social Trading Insights - Cổng thông tin điện tử tỉnh Tây Ninh
Tenaya Therapeutics (TNYA) seeks approval for larger equity plan and director slate - Stock Titan
[ARS] Tenaya Therapeutics, Inc. SEC Filing - Stock Titan
Tenaya Therapeutics Receives 'Moderate Buy' Rating from Brokerages - National Today
Tenaya Therapeutics (TNYA) Stock Analysis Report | Financials & Insights - Benzinga España
LifeSci Capital Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $3 - Moomoo
TNYA Stock Price, Quote & Chart | TENAYA THERAPEUTICS INC (NASDAQ:TNYA) - ChartMill
If You Invested $1,000 in Tenaya Therapeutics, Inc. (TNYA) - Stock Titan
William Blair analysts confident on Tenaya Therapeutics (TNYA) product pipeline - MSN
Revenue Check: Is Tenaya Therapeutics Inc in a long term uptrendTreasury Yields & Community Consensus Stock Picks - baoquankhu1.vn
Investor Mood: Is Tenaya Therapeutics Inc stock a value trap2026 Levels & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Tenaya Therapeutics (NASDAQ:TNYA) Shares Down 5%Here's What Happened - MarketBeat
Is Tenaya Therapeutics (TNYA) Stock Competitive Now | Price at $0.66, Down 4.98%Crowd Risk Alerts - Cổng thông tin điện tử tỉnh Tây Ninh
Tenaya Therapeutics Inc (TNYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
3.01%
자본화:
|
볼륨(24시간):